These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 37428202

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lack of synergistic nephrotoxicity between vancomycin and piperacillin/tazobactam in a rat model and a confirmatory cellular model.
    Pais GM, Liu J, Avedissian SN, Hiner D, Xanthos T, Chalkias A, d'Aloja E, Locci E, Gilchrist A, Prozialeck WC, Rhodes NJ, Lodise TP, Fitzgerald JC, Downes KJ, Zuppa AF, Scheetz MH.
    J Antimicrob Chemother; 2020 May 01; 75(5):1228-1236. PubMed ID: 32011685
    [Abstract] [Full Text] [Related]

  • 5. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ, Cowden C, Laskin BL, Huang YS, Gong W, Bryan M, Fisher BT, Goldstein SL, Zaoutis TE.
    JAMA Pediatr; 2017 Dec 04; 171(12):e173219. PubMed ID: 28973124
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
    Anderson CW, Cazares KS, Lustik MB, Patel SM, Denunzio TM.
    Mil Med; 2017 Sep 04; 182(9):e1773-e1778. PubMed ID: 28885936
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Piperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.
    LeCleir LK, Pettit RS.
    Pediatr Pulmonol; 2017 Aug 04; 52(8):1000-1005. PubMed ID: 28440913
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis.
    Luther MK, Timbrook TT, Caffrey AR, Dosa D, Lodise TP, LaPlante KL.
    Crit Care Med; 2018 Jan 04; 46(1):12-20. PubMed ID: 29088001
    [Abstract] [Full Text] [Related]

  • 15. Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
    Holsen MR, Meaney CJ, Hassinger AB, Fusco NM.
    Pediatr Crit Care Med; 2017 Dec 04; 18(12):e585-e591. PubMed ID: 28906422
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the Nephrotoxicity of Vancomycin in Combination With Cefepime, Meropenem, or Piperacillin/Tazobactam: A Prospective, Multicenter Study.
    Mullins BP, Kramer CJ, Bartel BJ, Catlin JS, Gilder RE.
    Ann Pharmacother; 2018 Jul 04; 52(7):639-644. PubMed ID: 29442542
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD, Drew RH.
    Pharmacotherapy; 2014 Jul 04; 34(7):670-6. PubMed ID: 24855041
    [Abstract] [Full Text] [Related]

  • 19. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA, Smith MN, Painter JT, Meena NK, Lusardi K.
    Pharmacotherapy; 2016 May 04; 36(5):463-71. PubMed ID: 26952639
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.